Ftse Mib
38.592,81
-0,48%
DAX
23.008,94
-1,87%
S&P 500
5.770,20
0,55%
NASDAQ
18.196,22
0,70%
Bitcoin
84.740,08
-1,64%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ aTyr Pharma Inc (ATYR) aTyr Pharma Inc (ATYR) Notizie

aTyr Pharma Inc

ATYR
3,38
0,30 (9,74%)
08 Mar 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
06/3/202522:02GLOBEaTyr Pharma Announces Fourth Positive DSMB Review for..
04/3/202514:00GLOBEaTyr Pharma to Webcast Conference Call Reporting Fourth..
24/2/202514:00GLOBEaTyr Pharma to Present at the Leerink Partners Global..
05/2/202500:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202500:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/1/202514:00GLOBEaTyr Pharma to Present Three Posters for Efzofitimod at the..
10/1/202522:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202522:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/12/202422:48EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
23/12/202422:42EDGAR2Form 8-K - Current report
17/12/202414:00GLOBEaTyr Pharma to Present at the 43rd Annual J.P. Morgan..
12/12/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202422:12EDGAR2Form 3 - Initial statement of beneficial ownership of..
12/12/202422:05EDGAR2Form 8-K - Current report
12/12/202422:00GLOBEaTyr Pharma Announces the Appointment of Eric Benevich to..
10/12/202414:00GLOBEaTyr Pharma Announces Third Positive DSMB Review for..
09/12/202414:00GLOBEaTyr Pharma to Present Preclinical Research Demonstrating..
15/11/202414:00GLOBEaTyr Pharma to Present Posters on tRNA Synthetase Candidate..
15/11/202400:51EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
07/11/202422:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202422:03EDGAR2Form 8-K - Current report
07/11/202422:01GLOBEaTyr Pharma Announces Third Quarter 2024 Results and..
31/10/202413:00GLOBEaTyr Pharma to Present at Upcoming Investor Conferences
15/10/202423:01EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
08/10/202414:00GLOBEaTyr Pharma’s Lead Therapeutic Candidate Efzofitimod for..
02/10/202414:00GLOBEaTyr Pharma Announces Publication Demonstrating Efficacy of..
21/8/202414:00GLOBEaTyr Pharma to Participate in September Investor Conferences
13/8/202422:00GLOBEaTyr Pharma Announces Second Quarter 2024 Results and..
06/8/202414:00GLOBEaTyr Pharma Announces Appointment of Jayant Aphale, PhD, as..
30/7/202414:00GLOBEaTyr Pharma Announces Research Study with Stanford Medicine
22/7/202414:00GLOBEaTyr Pharma Completes Enrollment in Global Pivotal Phase 3..
03/6/202414:00GLOBEaTyr Pharma Announces Nasdaq Stock Ticker Symbol Change from..
Apertura: 3,28 Min: 3,27 Max: 3,725
Chiusura: 3,08

La tua Cronologia

NASDAQ
ATYR
aTyr Pharma
BOV
VIVA3T
VIVARA
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci